Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Onco-Innovations Ltd. ( (TSE:ONCO) ).
Onco-Innovations Limited has closed a non-brokered private placement, issuing 1,870,000 units at $0.65 per unit for gross proceeds of $1,215,500, with each unit consisting of one common share and a three-year warrant exercisable at $0.75. The company also issued 18,700 shares as payment for administrative services related to the financing, which will support general corporate needs, working capital, and ongoing operational, research and development, and investor relations objectives.
All securities issued in the financing are subject to a statutory hold period of four months and one day under applicable securities laws. The raise strengthens Onco-Innovations’ capital position as it advances its solid tumour-focused technology and broader oncology strategy, while operating within Canadian and international securities law constraints on cross-border offerings.
More about Onco-Innovations Ltd.
Onco-Innovations Limited is a Canadian-based oncology company focused on cancer research and treatment. The firm pursues prevention and treatment of cancer through pioneering research and innovative solutions, and holds an exclusive worldwide license to patented technology targeting solid tumours.
Average Trading Volume: 29,585
Technical Sentiment Signal: Sell
Current Market Cap: C$84.6M
See more data about ONCO stock on TipRanks’ Stock Analysis page.